Jupiter Life Line Hospitals Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Key multi-specialty tertiary and quaternary healthcare provider with a track record of over 15 years, strong brand recognition and clinical expertise.
• 'All-hub-no-spoke' model with focus on quality patient care supported by modern infrastructure and technological capabilities.
• Ability to attract and retain skilled and experienced healthcare professionals.
• Track-record of operational and financial performance with a diversified revenue mix.
• Experienced and qualified professional management team with a focus on environmental, social and governance initiatives.

• The Hospital is highly dependent on its healthcare professionals including doctors and nurses, and any future inability to attract/ retain such professionals will adversely affect the Hospital business, financial condition and results of operations.
• Its revenues are significantly dependent on its hospital in Thane. Further, all the hospitals are located in the western regions of India. Any impact on the revenues of its Thane hospital or any change in the economic or political circumstances of western India or particularly in or around Thane, could materially affect its business, financial condition and results of operations.
• The Hospital industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labour and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, financial condition and results of operations.
• Any inability to pass on its costs including high medical equipment cost, manpower cost and infrastructure maintenance and repair cost, to its patients, may have an adverse impact on its business, financial condition and results of operations.
• Its ability to provide affordable healthcare depends on the maintenance of a high volume of patients, occupancy rates, managing project costs and effective capital management. Any increase in such costs could adversely affect its business, financial condition and results of operations.

• Strategically expand its footprint in western markets.
• Continue to recruit and retain skilled healthcare professionals.
• Pursue strategic inorganic growth opportunities in its focus micro-markets.
• Continue to improve quality of care and invest and employ latest technology.
• Strategically expand its footprint in western markets.